Cocaine-like price hike: China's new cancer drug is approved

Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.

Related Keywords

Yifan , Zhejiang , China , United States , Hong Kong , Colombia , Chinese , American , Teresa Bitetti , Cathy Eng , Wang Xiaodong , Eli Lilly , Dennis Lanfear , Acrotech Biopharma , Vanderbilt University Medical Centre , Hong Kong Laureate Forum , Chinese National Medical Products Administration , National Medical Insurance Administration , Takeda Pharmaceutical Company , Journal Of The American Medical Association , Merck Co , American Cancer Society , Exchange Commission On , Exchange Commission , National Medical Insurance , Evive Biotech , Hangzhou Based Yifan Pharmaceutical , Tokyo Based Takeda Pharmaceutical Company , American Medical Association , New Jersey Based Merck , American Cancer , New Jersey Based Acrotech Biopharma , Disease Control ,